Javascript must be enabled to continue!
Conformal predictive intervals in survival analysis: a resampling approach
View through CrossRef
ABSTRACT
The distribution-free method of conformal prediction has gained considerable attention in computer science, machine learning, and statistics. Candès et al. extended this method to right-censored survival data, addressing right-censoring complexity by creating a covariate shift setting, extracting a subcohort of subjects with censoring times exceeding a fixed threshold. Their approach only estimates the lower prediction bound for type I censoring, where all subjects have available censoring times regardless of their failure status. In medical applications, we often encounter more general right-censored data, observing only the minimum of failure time and censoring time. Subjects with observed failure times have unavailable censoring times. To address this, we propose a bootstrap method to construct 1- as well as 2-sided conformal predictive intervals for general right-censored survival data under different working regression models. Through simulations, our method demonstrates excellent average coverage for the lower bound and good coverage for the 2-sided predictive interval, regardless of working model is correctly specified or not, particularly under moderate censoring. We further extend the proposed method to several directions in medical applications. We apply this method to predict breast cancer patients’ future survival times based on tumor characteristics and treatment.
Title: Conformal predictive intervals in survival analysis: a resampling approach
Description:
ABSTRACT
The distribution-free method of conformal prediction has gained considerable attention in computer science, machine learning, and statistics.
Candès et al.
extended this method to right-censored survival data, addressing right-censoring complexity by creating a covariate shift setting, extracting a subcohort of subjects with censoring times exceeding a fixed threshold.
Their approach only estimates the lower prediction bound for type I censoring, where all subjects have available censoring times regardless of their failure status.
In medical applications, we often encounter more general right-censored data, observing only the minimum of failure time and censoring time.
Subjects with observed failure times have unavailable censoring times.
To address this, we propose a bootstrap method to construct 1- as well as 2-sided conformal predictive intervals for general right-censored survival data under different working regression models.
Through simulations, our method demonstrates excellent average coverage for the lower bound and good coverage for the 2-sided predictive interval, regardless of working model is correctly specified or not, particularly under moderate censoring.
We further extend the proposed method to several directions in medical applications.
We apply this method to predict breast cancer patients’ future survival times based on tumor characteristics and treatment.
Related Results
ecision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predi
ecision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predi
The scope of sensor networks and the Internet of Things spanning rapidly to diversified domains but not limited to sports, health, and business trading. In recent past, the sensors...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Abstract
Introduction
Although the efficacy of PD-L1 blockade has been evaluated in analyses that combine pharmacologically distinct antibodies, the specific efficacy and safety of...
Conformal Super-Biderivations on Lie Conformal Superalgebras
Conformal Super-Biderivations on Lie Conformal Superalgebras
In this paper, the conformal super-biderivations of two classes of Lie conformal superalgebras are studied. By proving some general results on conformal super-biderivations, we det...
REBALANCING DATA FOR CANCER-ASSOCIATED THROMBOSIS: COMPARISON OF DIFFERENT RESAMPLING APPROACH
REBALANCING DATA FOR CANCER-ASSOCIATED THROMBOSIS: COMPARISON OF DIFFERENT RESAMPLING APPROACH
Objective: Cancer-associated thrombosis (CAT) presents a complex challenge in oncology, exacerbated by data imbalances in related datasets that often lead to suboptimal outcomes in...
Two classes of Lie conformal superalgebras related to the Heisenberg–Virasoro Lie conformal algebra
Two classes of Lie conformal superalgebras related to the Heisenberg–Virasoro Lie conformal algebra
In this paper, we classify the Lie conformal superalgebras R=R0̄⊕R1̄, where R1̄ is of rank 1 and R0̄ is the Heisenberg–Virasoro Lie conformal algebra HV, which is a free C[∂]-modul...
Conformal (σ, τ)-derivations on lie conformal algebras
Conformal (σ, τ)-derivations on lie conformal algebras
In this paper, we focus on the conformal (?, ?)-derivation theory of Lie
conformal algebras. Firstly, we study the fundamental properties of
conformal (?, ?)-derivations. Sec...
Conformal Lie 2-algebras and conformal omni-Lie algebras
Conformal Lie 2-algebras and conformal omni-Lie algebras
The notions of conformal Lie 2-algebras and conformal omni-Lie algebras are introduced. It is proved that the category of conformal Lie 2-algebras and the category of 2-term confor...

